331 related articles for article (PubMed ID: 22379025)
1. Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2.
Cieply B; Riley P; Pifer PM; Widmeyer J; Addison JB; Ivanov AV; Denvir J; Frisch SM
Cancer Res; 2012 May; 72(9):2440-53. PubMed ID: 22379025
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2.
Cieply B; Farris J; Denvir J; Ford HL; Frisch SM
Cancer Res; 2013 Oct; 73(20):6299-309. PubMed ID: 23943797
[TBL] [Abstract][Full Text] [Related]
3. Dual roles of the transcription factor grainyhead-like 2 (GRHL2) in breast cancer.
Werner S; Frey S; Riethdorf S; Schulze C; Alawi M; Kling L; Vafaizadeh V; Sauter G; Terracciano L; Schumacher U; Pantel K; Assmann V
J Biol Chem; 2013 Aug; 288(32):22993-3008. PubMed ID: 23814079
[TBL] [Abstract][Full Text] [Related]
4. The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer.
Mooney SM; Talebian V; Jolly MK; Jia D; Gromala M; Levine H; McConkey BJ
J Cell Biochem; 2017 Sep; 118(9):2559-2570. PubMed ID: 28266048
[TBL] [Abstract][Full Text] [Related]
5. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
[TBL] [Abstract][Full Text] [Related]
6. GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification.
Chung VY; Tan TZ; Tan M; Wong MK; Kuay KT; Yang Z; Ye J; Muller J; Koh CM; Guccione E; Thiery JP; Huang RY
Sci Rep; 2016 Feb; 6():19943. PubMed ID: 26887977
[TBL] [Abstract][Full Text] [Related]
7. Grainyhead-like 2 Reverses the Metabolic Changes Induced by the Oncogenic Epithelial-Mesenchymal Transition: Effects on Anoikis.
Farris JC; Pifer PM; Zheng L; Gottlieb E; Denvir J; Frisch SM
Mol Cancer Res; 2016 Jun; 14(6):528-38. PubMed ID: 27084311
[TBL] [Abstract][Full Text] [Related]
8. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
[TBL] [Abstract][Full Text] [Related]
9. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
Howe EN; Cochrane DR; Richer JK
Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of
Carpinelli MR; de Vries ME; Auden A; Butt T; Deng Z; Partridge DD; Miles LB; Georgy SR; Haigh JJ; Darido C; Brabletz S; Brabletz T; Stemmler MP; Dworkin S; Jane SM
Dis Model Mech; 2020 Mar; 13(3):. PubMed ID: 32005677
[TBL] [Abstract][Full Text] [Related]
11. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
12. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.
Thomas C; Rajapaksa G; Nikolos F; Hao R; Katchy A; McCollum CW; Bondesson M; Quinlan P; Thompson A; Krishnamurthy S; Esteva FJ; Gustafsson JÅ
Breast Cancer Res; 2012 Nov; 14(6):R148. PubMed ID: 23158001
[TBL] [Abstract][Full Text] [Related]
13. Grainyhead-like 2 (GRHL2) regulates epithelial plasticity in pancreatic cancer progression.
Nishino H; Takano S; Yoshitomi H; Suzuki K; Kagawa S; Shimazaki R; Shimizu H; Furukawa K; Miyazaki M; Ohtsuka M
Cancer Med; 2017 Nov; 6(11):2686-2696. PubMed ID: 28960866
[TBL] [Abstract][Full Text] [Related]
14. Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression.
Xiang X; Deng Z; Zhuang X; Ju S; Mu J; Jiang H; Zhang L; Yan J; Miller D; Zhang HG
PLoS One; 2012; 7(12):e50781. PubMed ID: 23284647
[TBL] [Abstract][Full Text] [Related]
15. Grainyhead-like 2 inhibits the coactivator p300, suppressing tubulogenesis and the epithelial-mesenchymal transition.
Pifer PM; Farris JC; Thomas AL; Stoilov P; Denvir J; Smith DM; Frisch SM
Mol Biol Cell; 2016 Aug; 27(15):2479-92. PubMed ID: 27251061
[TBL] [Abstract][Full Text] [Related]
16. Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
Ahmad A; Aboukameel A; Kong D; Wang Z; Sethi S; Chen W; Sarkar FH; Raz A
Cancer Res; 2011 May; 71(9):3400-9. PubMed ID: 21389093
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of FXYD3 is induced by transforming growth factor-β signaling via ZEB1/δEF1 in human mammary epithelial cells.
Yamamoto H; Mukaisho K; Sugihara H; Hattori T; Asano S
Biol Pharm Bull; 2011; 34(3):324-9. PubMed ID: 21372379
[TBL] [Abstract][Full Text] [Related]
18. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
Kong X; Ding X; Li X; Gao S; Yang Q
Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
[TBL] [Abstract][Full Text] [Related]
19. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
Gregory PA; Bert AG; Paterson EL; Barry SC; Tsykin A; Farshid G; Vadas MA; Khew-Goodall Y; Goodall GJ
Nat Cell Biol; 2008 May; 10(5):593-601. PubMed ID: 18376396
[TBL] [Abstract][Full Text] [Related]
20. Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.
Sarrio D; Franklin CK; Mackay A; Reis-Filho JS; Isacke CM
Stem Cells; 2012 Feb; 30(2):292-303. PubMed ID: 22102611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
